144 related articles for article (PubMed ID: 27377813)
1. The Potent Inhibitory Effect of a Naproxen-Appended Cobalt(III)-Cyclam Complex on Cancer Stem Cells.
Cressey PB; Eskandari A; Bruno PM; Lu C; Hemann MT; Suntharalingam K
Chembiochem; 2016 Sep; 17(18):1713-8. PubMed ID: 27377813
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stem Cell and Bulk Cancer Cell Active Copper(II) Complexes with Vanillin Schiff Base Derivatives and Naproxen.
Lu C; Eskandari A; Cressey PB; Suntharalingam K
Chemistry; 2017 Aug; 23(47):11366-11374. PubMed ID: 28658520
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes.
Boodram JN; Mcgregor IJ; Bruno PM; Cressey PB; Hemann MT; Suntharalingam K
Angew Chem Int Ed Engl; 2016 Feb; 55(8):2845-50. PubMed ID: 26806362
[TBL] [Abstract][Full Text] [Related]
4. Diflunisal-adjoined cobalt(iii)-polypyridyl complexes as anti-cancer stem cell agents.
Abe DO; Eskandari A; Suntharalingam K
Dalton Trans; 2018 Oct; 47(39):13761-13765. PubMed ID: 30225483
[TBL] [Abstract][Full Text] [Related]
5. A breast cancer stem cell-selective, mammospheres-potent osmium(VI) nitrido complex.
Suntharalingam K; Lin W; Johnstone TC; Bruno PM; Zheng YR; Hemann MT; Lippard SJ
J Am Chem Soc; 2014 Oct; 136(41):14413-6. PubMed ID: 25247635
[TBL] [Abstract][Full Text] [Related]
6. Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines.
Baecker D; Sagasser J; Karaman S; Hörmann AA; Gust R
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100408. PubMed ID: 34893997
[TBL] [Abstract][Full Text] [Related]
7. Cobalt(III)-Macrocyclic Scaffolds with Anti-Cancer Stem Cell Activity.
Fang J; Gerschel P; Singh K; Apfel UP; Suntharalingam K
Molecules; 2024 Jun; 29(12):. PubMed ID: 38930809
[TBL] [Abstract][Full Text] [Related]
8. A Breast Cancer Stem Active Cobalt(III)-Cyclam Complex Containing Flufenamic Acid with Immunogenic Potential.
Fang J; Orobator ON; Olelewe C; Passeri G; Singh K; Awuah SG; Suntharalingam K
Angew Chem Int Ed Engl; 2024 Feb; 63(6):e202317940. PubMed ID: 38063406
[TBL] [Abstract][Full Text] [Related]
9. The breast cancer stem cell potency of copper(ii) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles.
Eskandari A; Boodram JN; Cressey PB; Lu C; Bruno PM; Hemann MT; Suntharalingam K
Dalton Trans; 2016 Nov; 45(44):17867-17873. PubMed ID: 27774561
[TBL] [Abstract][Full Text] [Related]
10. Structural alterations based on naproxen scaffold: Synthesis, evaluation of antitumor activity and COX-2 inhibition, and molecular docking.
El-Husseiny WM; El-Sayed MA; Abdel-Aziz NI; El-Azab AS; Asiri YA; Abdel-Aziz AA
Eur J Med Chem; 2018 Oct; 158():134-143. PubMed ID: 30216848
[TBL] [Abstract][Full Text] [Related]
11. Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action.
Ott I; Schmidt K; Kircher B; Schumacher P; Wiglenda T; Gust R
J Med Chem; 2005 Jan; 48(2):622-9. PubMed ID: 15658875
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
13. The Discrete Breast Cancer Stem Cell Mammosphere Activity of Group 10-Bis(azadiphosphine) Metal Complexes.
Xiao Z; Johnson A; Singh K; Suntharalingam K
Angew Chem Int Ed Engl; 2021 Mar; 60(12):6704-6709. PubMed ID: 33274606
[TBL] [Abstract][Full Text] [Related]
14. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
[TBL] [Abstract][Full Text] [Related]
15. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects.
Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB
Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833
[TBL] [Abstract][Full Text] [Related]
16. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
[TBL] [Abstract][Full Text] [Related]
17. Induction of Necroptosis in Cancer Stem Cells using a Nickel(II)-Dithiocarbamate Phenanthroline Complex.
Flamme M; Cressey PB; Lu C; Bruno PM; Eskandari A; Hemann MT; Hogarth G; Suntharalingam K
Chemistry; 2017 Jul; 23(40):9674-9682. PubMed ID: 28556445
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cytotoxic activity and genotoxicity of structurally well characterized potent cobalt(II) phen-based antitumor drug entities: An in vitro and in vivo approach.
Khan HY; Ansari MO; Shadab GGHA; Tabassum S; Arjmand F
Bioorg Chem; 2019 Jul; 88():102963. PubMed ID: 31071506
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.
Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K
Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422
[TBL] [Abstract][Full Text] [Related]
20. 2, 3-Diaryl-5-ethylsulfanylmethyltetrahydrofurans as a new class of COX-2 inhibitors and cytotoxic agents.
Singh P; Mittal A; Kaur S; Holzer W; Kumar S
Org Biomol Chem; 2008 Aug; 6(15):2706-12. PubMed ID: 18633528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
